Does PONATINIB Cause Product dose omission issue? 817 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 817 reports of Product dose omission issue have been filed in association with PONATINIB (Iclusig). This represents 8.2% of all adverse event reports for PONATINIB.
817
Reports of Product dose omission issue with PONATINIB
8.2%
of all PONATINIB reports
159
Deaths
481
Hospitalizations
How Dangerous Is Product dose omission issue From PONATINIB?
Of the 817 reports, 159 (19.5%) resulted in death, 481 (58.9%) required hospitalization, and 4 (0.5%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PONATINIB. However, 817 reports have been filed with the FAERS database.
What Other Side Effects Does PONATINIB Cause?
Death (1,735)
Off label use (1,071)
Fatigue (687)
Rash (639)
Headache (553)
Pyrexia (542)
Nausea (466)
Hospitalisation (459)
Constipation (435)
Drug ineffective (406)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which PONATINIB Alternatives Have Lower Product dose omission issue Risk?
PONATINIB vs PONATINIB\PONATINIB
PONATINIB vs PONESIMOD
PONATINIB vs PORACTANT ALFA
PONATINIB vs PORFIMER
PONATINIB vs POSACONAZOLE